# FDA Inspection 1193493 - GlaxoSmithKline Biologicals - November 08, 2022

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/e865d539-7363-43f7-b06a-9bb6bef4b8da
Source feed: FDA_Inspections

> FDA Inspection 1193493 for GlaxoSmithKline Biologicals on November 08, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1193493
- Company Name: GlaxoSmithKline Biologicals
- Inspection Date: 2022-11-08
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1280789 - 2025-08-05](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/7dbd6c72-5fb2-40c1-b76c-528641fc7782)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals/a1983e6a-fbe9-4c98-8efb-39f62ca09624

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d